Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pasini

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Human Mutation|February 5, 2000
Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. OnlineV M De Benedetti, P Radice, B Pasini, et al.
Oncogene|February 20, 1997
Identification of Shc docking site on Ret tyrosine kinaseE Arighi, L Alberti, F Torriti, et al.
Oncogene|June 10, 1998
Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulationI Bongarzone, E Vigano, L Alberti, et al.
Nature|January 27, 1994
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinomaR M Hofstra, R M Landsvater, I Ceccherini, et al.
Bulletin of Entomological Research|September 6, 2021
Oscillation, synchrony, and multi-factor patterns between cereal aphids and parasitoid populations in southern BrazilEduardo Engel, Douglas Lau, Wesley A C Godoy, et al.
Oncogene|May 29, 1997
Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogeneI Ceccherini, B Pasini, F Pacini, et al.
Histology and Histopathology|March 1, 2005
Immunocytochemical developmental patterns of the thoracolumbar sympathetic chain in the chick and a comparison with its adrenal counterpartI Sánchez-Montesinos, J R Mérida-Velasco, F Hita-Contreras, et al.
Molecular and Cellular Biology|May 1, 1996
The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase CgammaM G Borrello, L Alberti, E Arighi, et al.
Lancet (London, England)|December 29, 2000
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study GroupS A Narod, J S Brunet, P Ghadirian, et al.
British Journal of Cancer|September 15, 2001
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutationG Della Torre, B Pasini, S Frigerio, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Human Mutation|February 5, 2000
Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. OnlineV M De Benedetti, P Radice, B Pasini, et al.
Oncogene|February 20, 1997
Identification of Shc docking site on Ret tyrosine kinaseE Arighi, L Alberti, F Torriti, et al.
Oncogene|June 10, 1998
Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulationI Bongarzone, E Vigano, L Alberti, et al.
Nature|January 27, 1994
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinomaR M Hofstra, R M Landsvater, I Ceccherini, et al.
Bulletin of Entomological Research|September 6, 2021
Oscillation, synchrony, and multi-factor patterns between cereal aphids and parasitoid populations in southern BrazilEduardo Engel, Douglas Lau, Wesley A C Godoy, et al.
Oncogene|May 29, 1997
Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogeneI Ceccherini, B Pasini, F Pacini, et al.
Histology and Histopathology|March 1, 2005
Immunocytochemical developmental patterns of the thoracolumbar sympathetic chain in the chick and a comparison with its adrenal counterpartI Sánchez-Montesinos, J R Mérida-Velasco, F Hita-Contreras, et al.
Molecular and Cellular Biology|May 1, 1996
The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase CgammaM G Borrello, L Alberti, E Arighi, et al.
Lancet (London, England)|December 29, 2000
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study GroupS A Narod, J S Brunet, P Ghadirian, et al.
British Journal of Cancer|September 15, 2001
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutationG Della Torre, B Pasini, S Frigerio, et al.
Pageof 5